Clinical Trial Update: Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the safety and diagnostic efficacy of Mangoral in participants with focal liver lesions and severe renal impairment have been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Liver Diseases

Drugs mentioned

• Mangoral (mangafodipir trisodium)

Snippet

Sponsor: Ascelia Pharma AB | Conditions: Known or Suspected Focal Liver Lesions, Severe Renal Impairment | Phase 3 | Status: COMPLETED | Results posted: 2025-02-06